Release Date: 25/08/11 10:55 Summary: Frederic Briens appointed as new CEO Price Sensitive: Yes Download Document 221.26KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%